Pharmas expect strong Q3 income; Dealmaking heats up in vaccine market;

> Despite the lagging economy, times are fine for pharmaceutical companies. Three of the biggest are announcing their Q3 earnings this week, and their numbers are expected to look good. FiercePharma

> Of late, the vaccine market has become one of the hottest niches in biopharma. Lately, that's led to a string of big M&A deals, and will probably spawn several more, experts say. FierceVaccines

> Though healthcare financial indicators are getting better, many construction projects are still mothballed, and it's not clear when building will begin again. FierceHealthFinance

> Given how widely treatments vary from child to child, building a pediatric HIT system can be an extremely complex project. Still, that's just the challenge Children's Hospital of Boston took on recently. FierceHealthIT

And Finally... Don't, and I mean don't, come between a teenager and their cellphone. That is, unless you don't mind getting your butt kicked. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.